S1TE34.SA STERIS plc
- Market cap
- BRL 102B
- P/E
- 24.0x
- P/B
- 2.73x
- ROE
- 11.1%
- Dividend yield
- 1.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is S1TE34.SA undervalued?
Graham numberS1TE34.SA trades 70.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
STERIS plc fundamental analysis
No fundamental analysis for STERIS plc yet.
STERIS plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment use…
Full company profileSTERIS plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
STERIS plc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 4.22B | 4.54B | 5.14B | 5.46B | 5.94B | 5.97B |
| Gross Profit | 1.88B | 1.98B | 2.22B | 2.40B | 2.63B | 2.74B |
| Operating Income | 478M | 791M | 836M | 874M | 1.11B | 1.14B |
| EBITDA | - | 1.34B | 1.41B | 1.36B | 1.59B | 1.65B |
| Net Income | 244M | 107M | 378M | 615M | 782M | 800M |
| EPS | 2.44 | 1.09 | 3.83 | 6.25 | 8.00 | 8.21 |
| Balance Sheet | ||||||
| Total Assets | 11.4B | 10.8B | 11.1B | 10.1B | 10.7B | 10.7B |
| Total Liabilities | 4.88B | 4.74B | 4.76B | 3.54B | 3.54B | 3.51B |
| Shareholders' Equity | 6.53B | 6.08B | 6.30B | 6.60B | 7.18B | 7.21B |
| Cash & Short-term Investments | 348M | 208M | 207M | 172M | 440M | 482M |
| Cash Flow | ||||||
| Operating Cash Flow | 685M | 757M | 973M | 1.15B | 1.34B | 1.47B |
| Capital Expenditure | 288M | 362M | 360M | 370M | 369M | 350M |
| Free Cash Flow | 397M | 395M | 613M | 778M | 972M | 1.12B |
| Ratios | ||||||
| ROE | 3.7% | 1.8% | 6.0% | 9.3% | 10.9% | 11.1% |
| ROA | 2.1% | 1.0% | 3.4% | 6.1% | 7.3% | 7.5% |
| Net Profit Margin | 5.8% | 2.4% | 7.4% | 11.3% | 13.2% | 13.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
STERIS plc dividends
- Dividend yield
- 1.03%
- Forward dividend
- 0.54 BRL
- Payout ratio
- 30.9%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | USD 242M | 2.47 | 30.9% |
| 2025 | USD 220M | 2.24 | 35.8% |
| 2024 | USD 201M | 2.03 | 53.0% |
| 2023 | USD 183M | 1.86 | 171.4% |
| 2022 | USD 163M | 1.63 | 66.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns STERIS plc
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 1.95B
- Free float 97.1M
STERIS plc company profile
- Company name
- STERIS plc
- Ticker
- S1TE34.SA
- Exchange
- Sao Paulo Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 17,937
- Fiscal year end
- March
- Address
- 5960 Heisley Road, Mentor, OH, United States, 44060
- Phone
- 440 354 2600
- Website
- steris.com
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
STERIS plc management
10- Mr. Daniel A. CarestioPresident, CEO & Director · born 1973
- Ms. Karen L. BurtonSenior VP, CFO & Chief Accounting Officer · born 1968
- Mr. John Adam ZangerleSenior VP, General Counsel & Secretary · born 1967
- Ms. Mary Clare FraserSVP & Chief Human Resources Officer · born 1970
- Mr. Cary L. MajorsSenior VP & President of Healthcare · born 1975
- Ms. Julie WinterVice President of Investor Relations & Corporate Communications
- Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer
- Ms. Julia K. MadsenSenior VP & GM of Life Sciences · born 1965
- Mr. Andrew XilasSenior VP & GM of Dental · born 1965
- Mr. Kenneth E. KohlerSenior VP & GM of AST · born 1963